Childhood emotional trauma significantly elevates psoriasis risk by disrupting immune responses, new research reveals. Early ...

Obesity significantly impacts skin health, leading to common issues like dark patches (acanthosis nigricans) and skin tags ...

Psoriasis can feel like an uninvited guest that shows up on your skin and refuses to leave. Those red, scaly patches—often ...

Copenhagen University Hospital–Herlev and Gentofte led a nationwide registry study that the authors claim shows a "pattern ...

Subgroup analyses from one of the agent's pivotal trials showed that 29.5% of adolescents receiving icotrokinra achieved PASI ...

The severe stress caused by family upheaval might tax a child's immune system in ways that increase their chances of ...

Give your skin the natural care it deserves with Thena Natural Wellness's ultimate Skin Healing Cream! Our unique formula is ...

On World Psoriasis Day 2025, know how stress may spark flare-ups of Psoriasis, why the link matters, and what you can do to ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...

A mutation previously linked to skin disorders like psoriasis may also play a surprising role in gut health, according to new research published by scientists at VIB-UGent and colleagues from UGent, ...

More than 50% of patients with psoriasis are eligible for systemic treatment, and nearly 90% would switch to an effective oral therapy with a favorable safety profile.

Johnson & Johnson (NYSE: JNJ) today announced new long-term 52-week data from the Phase 3 ICONIC-TOTAL studya evaluating icotrokinra, a first-in-class investigational targeted oral peptide that ...